Omada Health, Inc.·4

Jun 18, 4:23 PM ET

ROOT JONATHAN D 4

4 · Omada Health, Inc. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Omada Health (OMDA) Director Jonathan Root Receives RSU Award

What Happened

  • Jonathan D. Root, a director of Omada Health, was awarded 10,882 restricted stock units (RSUs) on June 16, 2026. The grant is reported as an award (transaction code A) with an acquisition price of $0.00. The RSUs convert 1:1 into common shares upon vesting; the filing does not state an immediate cash value because value depends on Omada’s share price at vesting.

Key Details

  • Transaction date: 2026-06-16; Form 4 filed: 2026-06-18.
  • Transaction type/code: Award (A) — 10,882 RSUs granted at $0.00.
  • Vesting: 100% of the RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting, subject to continued service (per footnote).
  • Shares owned after transaction: not disclosed in this filing.
  • No 10b5-1 plan, tax-withholding, or cashless sale noted in the filing.
  • Filing timeliness: reported two days after the grant (appears timely).

Context

  • This is a grant of restricted stock units to a board director, not an open-market purchase or sale. RSU awards are common compensation for directors and executives; they only convert to tradable shares if and when they vest and any applicable transfer restrictions lapse. The $0 acquisition price reflects that these were granted, not purchased; their ultimate value will equal the number of vested shares times Omada’s stock price at vesting.

Insider Transaction Report

Form 4
Period: 2026-06-16
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-16+10,882191,057 total
Footnotes (1)
  • [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root|2026-06-18

Documents

1 file
  • 4
    form4.xmlPrimary